Current status: treatment of acute leukemia.
D000208:Acute Disease; D001215:Asparaginase / Q000627:therapeutic use*; D001500:BCG Vaccine; D016026:Bone Marrow Transplantation; D003630:Daunorubicin / Q000627:therapeutic use*; D004357:Drug Synergism; D006801:Humans; D007111:Immunity, Cellular; D007116:Immunization, Passive; D007938:Leukemia / Q000188:drug therapy*; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D001500:BCG Vaccine; D014750:Vincristine; D015122:Mercaptopurine; D001215:Asparaginase; D011241:Prednisone; D008727:Methotrexate; D003630:Daunorubicin